(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

PODD newsletter featured CEO Choi in its interview, "Harnessing the Power of Exosomes"

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 21-03-05 17:18
  • 조회 : 137회

첨부파일

본문

 

26 Feb 2021

 

PODD newsletter featured CEO Choi in its interview, "Harnessing the Power of Exosomes"


PODD(Partnership Opportunities in Drug Delivery) newsletter interviewed Chulhee Choi, MD, PhD, founder of ILIAS Biologics, Inc. and a pioneer in exosome-based drug delivery for its February issue: 'Delivery of Next-Generation Modalities.' Dr. Choi developed an exosome-based drug delivery system platform technology, EXPLOR®, which became the foundation of ILIAS Biologics, Inc.
Please find the full article in the attached PDF file.



개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기